Akari Therapeutics PLC 8-K Filing
Ticker: AKTX · Form: 8-K · Filed: Aug 19, 2025 · CIK: 1541157
Sentiment: neutral
Filing Stats: 525 words · 2 min read · ~2 pages · Grade level 11.4 · Accepted 2025-08-19 08:00:23
Key Financial Figures
- $0.0001 — tal Market Ordinary Shares, par value $0.0001 per share* *Trading, but only in conn
Filing Documents
- form8-k.htm (8-K) — 38KB
- ex99-1.htm (EX-99.1) — 15KB
- ex99-1_001.jpg (GRAPHIC) — 167KB
- ex99-1_002.jpg (GRAPHIC) — 367KB
- ex99-1_003.jpg (GRAPHIC) — 156KB
- ex99-1_004.jpg (GRAPHIC) — 161KB
- ex99-1_005.jpg (GRAPHIC) — 126KB
- ex99-1_006.jpg (GRAPHIC) — 194KB
- ex99-1_007.jpg (GRAPHIC) — 198KB
- ex99-1_008.jpg (GRAPHIC) — 175KB
- ex99-1_009.jpg (GRAPHIC) — 202KB
- ex99-1_010.jpg (GRAPHIC) — 834KB
- ex99-1_011.jpg (GRAPHIC) — 208KB
- ex99-1_012.jpg (GRAPHIC) — 146KB
- ex99-1_013.jpg (GRAPHIC) — 199KB
- ex99-1_014.jpg (GRAPHIC) — 180KB
- ex99-1_015.jpg (GRAPHIC) — 172KB
- ex99-1_016.jpg (GRAPHIC) — 173KB
- ex99-1_017.jpg (GRAPHIC) — 149KB
- ex99-1_018.jpg (GRAPHIC) — 212KB
- ex99-1_019.jpg (GRAPHIC) — 779KB
- ex99-1_020.jpg (GRAPHIC) — 116KB
- ex99-1_021.jpg (GRAPHIC) — 202KB
- ex99-1_022.jpg (GRAPHIC) — 173KB
- 0001641172-25-024732.txt ( ) — 7541KB
- aktx-20250819.xsd (EX-101.SCH) — 4KB
- aktx-20250819_def.xml (EX-101.DEF) — 26KB
- aktx-20250819_lab.xml (EX-101.LAB) — 36KB
- aktx-20250819_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 5KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Akari Therapeutics, Plc Date: August 19, 2025 By: /s/ Torsten Hombeck Torsten Hombeck Chief Financial Officer